Search research articles
Contact Us
Filters
Showing results (81-90 of 125) with videos related to
Page
of 13
Sort By:
Experimental Hematology
|
August 1, 1986
Sialylated glycolipid antigens on human leukemic cell lines
S L Spitalnik, P F Spitalnik, C I Civin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1999
Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen
R K Zhong, A D Donnenberg, H F Zhang, et al.
International Journal of Breast Cancer
|
February 2, 2012
Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support
A von Drygalski, T B Tran, K Messer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 5, 2002
Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support
A Bashey, S Sundaram, S Corringham, et al.
Blood
|
December 1, 1983
Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia
E D Ball, G M Bernier, G G Cornwell, et al.
Bone Marrow Transplantation
|
March 1, 1996
Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies
M deMagalhaes-Silverman, E J Bloom, A Donnenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Phase I clinical trial of serotherapy in patients with acute myeloid leukemia with an immunoglobulin M monoclonal antibody to CD15
E D Ball, K Selvaggi, D Hurd, et al.
Bone Marrow Transplantation
|
February 2, 1997
Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
J E Kiss, W B Rybka, A Winkelstein, et al.
Cancer Research
|
August 15, 1996
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)
R A Henderson, M T Nimgaonkar, S C Watkins, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
May 15, 2001
Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH(2)NH]-Phe(14))BN(6-14) and D-Trp-Gln-Trp-NH(2)
M Mokotoff, Y M Mocarski, B L Gentsch, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 125) with videos related to
Sort By:
Page
of 13
Experimental Hematology
|
August 1, 1986
Sialylated glycolipid antigens on human leukemic cell lines
S L Spitalnik, P F Spitalnik, C I Civin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 22, 1999
Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen
R K Zhong, A D Donnenberg, H F Zhang, et al.
International Journal of Breast Cancer
|
February 2, 2012
Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support
A von Drygalski, T B Tran, K Messer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 5, 2002
Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support
A Bashey, S Sundaram, S Corringham, et al.
Blood
|
December 1, 1983
Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia
E D Ball, G M Bernier, G G Cornwell, et al.
Bone Marrow Transplantation
|
March 1, 1996
Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies
M deMagalhaes-Silverman, E J Bloom, A Donnenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Phase I clinical trial of serotherapy in patients with acute myeloid leukemia with an immunoglobulin M monoclonal antibody to CD15
E D Ball, K Selvaggi, D Hurd, et al.
Bone Marrow Transplantation
|
February 2, 1997
Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
J E Kiss, W B Rybka, A Winkelstein, et al.
Cancer Research
|
August 15, 1996
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)
R A Henderson, M T Nimgaonkar, S C Watkins, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society
|
May 15, 2001
Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH(2)NH]-Phe(14))BN(6-14) and D-Trp-Gln-Trp-NH(2)
M Mokotoff, Y M Mocarski, B L Gentsch, et al.
Page
of 13